An Open Letter to JDRF with Four Key Recommendations

May 21, 2019

This report outlines four key recommendations for the JDRF Board of Directors and the new CEO to consider during their planning process for the upcoming fiscal year. These recommendations are based upon the priorities and wishes of the T1D community as demonstrated in semi-annual JDCA surveys. (Click here to view)


A Practical Cure for T1D: The Four Research Pathways

May 13, 2019

A Practical Cure is any solution which minimizes the disruptive aspects of T1D, delivers a near-normal quality of life and has a chance to be available within the next 15 years. It is aligned with the wishes and desires of people who are currently living with type 1 diabetes. Click here to read more.


T1D Research Trials Throughout the World

May 2, 2019

This is the seventh annual review of all active type 1 diabetes trials currently in human testing. This year, in addition to all clinical trials active in the US, we also included trials listed in the official registries of the EU, Australia, China, Japan, and India. Click here to read more.


JDRF T1D Fund Two-Year Retrospective

April 19, 2019

The JDRF T1D Fund was launched as a subsidiary of JDRF in December 2016. This report examines the Fund's impact on T1D research over the past two years. Click here to read more.


Aaron Kowalski Named JDRF President and CEO

April 9, 2019

This report provides a quick update on JDRFs new President and CEO, Aaron Kowalski. Click here to read more.


Practical Cure Update: ViaCyte

April 4, 2019

This report focuses on ViaCyte’s islet cell replacement therapies, identified as a Practical Cure in the 2018 State of the Cure for T1D, and features an interview with ViaCyte president and CEO Paul Laikind. Click here to read more.


JDRF Payroll Doubled while Research Grant Spending Cut in Half Over Past Decade

March 25, 2019

This report examines JDRF's Payroll Expenses, which includes salaries, bonuses, and all other staffing expenses. Click here to read more.


T1D Financial Donor Priority Survey: Cure Research Remains #1

March 14, 2019

This is the seventh annual survey-based report on the giving priorities of T1D donors. The key takeaway is the same as all prior years: the number one reason people make donations to diabetes charities and/or participate in fundraising activities such as walks and galas is to find a cure. Click here to read more.


JDRF Internal Costs for Administering Research Grants

March 7, 2019

This is a third in a series of reports on JDRF financials. The main takeaway is that JDRF administration cost for each dollar of actual research grants have increased 350 percent since 2008 while research grant spending is down 50 percent. Click here to read more.


2018 JDRF Revenue and Expenses Overview

February 21, 2019

This report provides an overview of JDRF's 2018 revenue and expenses, released last week. Based on publicly available tax and financial documents, it shows how JDRF generates its revenue and how it utilizes those funds. Click here to read more.


2018 JDRF Financials in Three Charts

February 14, 2019

This report provides an overview of JDRF's 2018 financial statements, released this week. Based on publicly available tax and financial documents, it show how JDRF generates its revenue and how it utilizes those funds. Click here to read more. 


encapsulation: an overview of competitors

January 22, 2019

This report will review the evolution of encapsulation therapies and examine all companies currently developing encapsulation devices. Encapsulation is a form of cell transplantation, one of the four JDCA Practical Cure Pathways. Click here to read more.


2018 State of the cure for type 1 diabetes

January 14, 2019

This is the seventh annual addition of this report. It summarizes progress made during 2018 toward a Practical Cure for type 1 diabetes. Click here to read more.